Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227669
Status:
COMPLETED
Last Update Posted:
2016-08-30
First Post:
2005-09-26
Brief Title:
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed Unresectable Uterine or Soft Tissue Leiomyosarcoma
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-26
First Submit QC Date:
September 26 2005
Study First Post Date:
2005-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-29
Last Update Post Date:
2016-08-30
Last Update Post Date Type:
ESTIMATED